A new study being published in the October issue of the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry has found that cannabinoids – compounds found in cannabis – can help to improve muscle rigidity (a “freezing” of the muscles), one of the primary symptoms of Parkinson’s disease, and may slow the progression of the disease.
A new study published by the British Journal of Pharmacology has found that cannabis can stop seizures due to its “significant anticonvulsant effects”.
For the study researchers used an extract made from the whole cannabis plant, and used the substance on a number of animal models – using rats and mice – and found that the extract was able to effectively stop seizures.
A new government funded study published in the journal Psychiatry Research has found that heavy cannabis use leads to better emotional memory and brain function in those with schizophrenia.
For the study – which was conducted at the Department of Psychiatry at the University of Montreal – researchers performed a magnetic resonance imaging study of emotional memory in patients with schizophrenia and cannabis abuse.
A new study funded by the National Institute for Translational Medicine, and published in last month’s issue of the journal Molecular Neurobiology, has found that cannabis may treat, as well as reverse the symptoms of neurodegenerative diseases such as Parkinson’s and Alzheimer’s.
According to researchers; “Our findings support the potential of cannabidiol in reversing cognitive decline and its clinical use in treating neurodegenerative disorders such as Parkinson’s Disease and Alzheimer’s Disease.”
A new study published in the journal Environmental Toxicology and Pharmacology has found that cannabidiol – a compound of cannabis – may protect the heart from the dangerous side effects associated with the popular cancer drug doxorubicin.
For the study, the “potential protective effect of cannabidiol, the major non-psychotropic Cannabis constituent, was investigated against doxorubicin cardiotoxicity in rats.”
A new study published by the journal Neuropharmacology has found that cannabinoids may reduce aggression, and improve social interactions.
For the study, researchers “examined the role of cannabinoid CB1 receptors (CB1r) in aggressive behavior”, and found that a compound meant to mimic THC (a prime compound of cannabis) “significantly decreased the aggression levels” of the mice that it was administered to. The researchers also examined mice which were bred without CB1 receptors, and found them to be more inherently aggressive than normal mice.
A new study conducted by Australia’s National Drug and Alcohol Research Centre (NDARC), and published online in the journal Drug and Alcohol Dependence, has found that “fun seeking” young adults are more likely to consume cannabis.
For the study researchers examined how much of a “fun seeker” someone is using the Behavioral Activation System scale; under this scale, being a sensation seeker, and being impulsive, ups your “fun seeking” score. The study concludes that those who scored highest on this scale were more likely to consume cannabis as they go through their adulthood.
A new study published by the Journal of Physiology and Pharmacology, and conducted by researchers at McMaster University, has concluded that THC – a prime compound in cannabis – may protect the body against digestive disorders, such as inflammatory bowel disease.
Researchers for the study used THC on rats, and found that the substance “could protect the lining of the stomach and intestine from injury and accelerate healing from inflammation.”
A new study published by the Journal Neurobiology of Disease has found that cannabidiol – a cannabinoid compound found in cannabis – can provide “long-lasting protection” against multiple sclerosis.
According to the study’s abstract, “Cannabidiol (CBD), a non-psychotropic cannabinoid constituent of Cannabis sativa, has potent anti-inflammatory and immunosuppressive properties”. Researchers state that; “Using this viral model of multiple sclerosis (MS), we demonstrate that CBD decreases the transmigration of blood leukocytes by downregulating the expression of vascular cell adhesion molecule-1 (VCAM-1), chemokines (CCL2 and CCL5) and the proinflammatory cytokine IL-1β, as well as by attenuating the activation of microglia”.
A new study published by the Journal of Drug Targeting examines how researchers have discovered a new method of using THC to combat cancer.
For the study, “Tetrahydrocannabinol [THC] was encapsulated into biodegradable microspheres by the oil-in-water (o/w) emulsion solvent evaporation method.”
Following this, the “efficacy of the microspheres was tested on different cancer cell lines”.